A Healthline summary highlights a Nature Metabolism review suggesting that fructose—especially from ultra-processed foods and sugar-sweetened beverages—may drive obesity and metabolic diseases by promoting fat production in the liver and disrupting metabolic pathways, with cautions that whole fruit is fine and a focus on reducing added fructose in processed foods.
A Nature Metabolism review argues fructose acts as a distinct metabolic signal from glucose, promoting fat production and lowering cellular energy, which may contribute to obesity, insulin resistance, and metabolic syndrome. The analysis notes fructose is consumed in common sweeteners like sucrose and high-fructose corn syrup and can also be produced internally from glucose, highlighting health risks beyond calories.
A Nature Metabolism review argues that fructose acts as a metabolic signal that drives fat production and depletes cellular energy, linking it to obesity and metabolic syndrome beyond calories, and noting that the body can generate fructose from glucose while high intake of free sugars remains a global risk.
A Nature Metabolism review argues that fructose acts as a distinct metabolic signal that promotes fat production and energy depletion, beyond simply adding calories; its effects may drive obesity, insulin resistance, and metabolic syndrome, and the authors highlight endogenous fructose production and rising free-sugar intake as ongoing health concerns.
Sugar activates the brain’s reward system and comes as glucose or fructose, which are processed differently: glucose prompts insulin release and energy storage, while fructose is sent to the liver and can be converted to fat. In excess, both raise triglycerides and may raise heart- and liver-related risks; repeated insulin spikes can fuel inflammation. The so-called 'sugar rush' is largely a myth, and when a sugar-induced dip occurs, people tend to eat more later. Timing matters: morning glucose responses are usually more favorable, and having sugar as part of a balanced meal with fiber, healthy fats, and protein helps blunt spikes. Moderation is best; avoid late-day sugar and be cautious with sugar substitutes, which may impact the gut/oral microbiome and can, in some cases, convert to fructose. Given that many people regularly eat sugary snacks (about 84% daily, with 79% up to three), reducing intake is sensible rather than demonizing it.
A high prevalence of fatty liver disease (84%) among Indian IT employees is linked to insulin resistance, high carbohydrate intake, and genetic factors, with sugar consumption—especially fructose—playing a key role in liver fat accumulation and inflammation, which can lead to serious liver and cardiovascular complications. Simply cutting calories or fat isn't enough; addressing insulin resistance and dietary habits is crucial.
Consuming fructose increases immune cell sensitivity to bacterial toxins, leading to heightened inflammation even in healthy individuals, which may have implications for metabolic health and disease risk.
Scientists have discovered that the enzyme ketohexokinase (KHK) plays a key role in alcohol addiction and liver damage by promoting fructose production during alcohol metabolism, and blocking this enzyme could lead to new treatments for these conditions.
A study shows that increasing dietary fiber, especially inulin-rich vegetables like garlic and onions, can prevent or reverse fatty liver disease caused by high fructose intake by altering gut bacteria, particularly Bacteroides acidifaciens, which helps break down fructose and protect the liver.
UC Irvine researchers found that consuming inulin, a vegetable-derived fiber, can reprogram gut bacteria to reduce fructose's harmful effects on the liver, potentially reversing fatty liver disease and insulin resistance, offering new avenues for nutrition-based disease prevention.
Recent research from Washington University in St. Louis reveals that the liver converts dietary fructose into nutrients that promote tumor growth in cancers like melanoma, breast, and cervical cancer. This study suggests that high-fructose consumption, primarily from high-fructose corn syrup, indirectly fuels cancer by increasing lipid availability in the blood, which tumors use for growth. The findings highlight the potential for dietary strategies and therapeutic approaches targeting fructose metabolism to combat cancer.
A study from Washington University in St. Louis suggests that high dietary fructose, particularly from processed foods containing high-fructose corn syrup, may promote cancer tumor growth in animal models. While fructose naturally found in fruits and vegetables is not harmful, excessive intake from processed foods can lead to increased lipid production, which may feed tumors. Experts emphasize the importance of understanding food labels and choosing natural sugars over processed ones to potentially reduce cancer risk.
New research suggests that fructose, a common sugar in American processed foods, may accelerate the growth of certain cancers, including skin, breast, and cervical tumors. The study found that fructose is converted by the liver into components that tumors use to grow, potentially making cancers more aggressive. Unlike natural fructose found in fruits, added fructose in foods like soda and salad dressing is prevalent in the US diet, with Americans consuming more than double the recommended amount of added sugar. Researchers advise cancer patients to avoid fructose when possible.
New research suggests that fructose, a sugar prevalent in high-fructose corn syrup, may accelerate cancer growth by being converted into lipids that cancer cells consume. Unlike glucose, fructose is metabolized only in the small intestine and liver, where it is transformed into compounds that support tumor growth. The study, published in Nature, highlights the potential impact of dietary fructose on cancer progression and suggests that reducing fructose intake could be beneficial for cancer patients. However, avoiding fructose is challenging due to its widespread presence in many foods.
A study published in Nature reveals that dietary fructose, commonly found in high-fructose corn syrup, promotes tumor growth in animal models by being converted into nutrients by the liver, rather than directly fueling tumors. This conversion increases circulating lipids, which cancer cells use to grow. The research suggests that reducing fructose intake could be beneficial for cancer patients and opens up potential therapeutic avenues targeting the metabolism of healthy cells to combat cancer. The study was funded by the National Institutes of Health.